4-107931691-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_183075.3(CYP2U1):c.48G>A(p.Trp16*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000253 in 1,186,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_183075.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000253 AC: 3AN: 1186330Hom.: 0 Cov.: 30 AF XY: 0.00000348 AC XY: 2AN XY: 574124
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp16*) in the CYP2U1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP2U1 are known to be pathogenic (PMID: 23176821, 26936192, 27292318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 35499206). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.